ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,819, issued on Nov. 11, was assigned to 712 North Inc. (Oakland, Calif.).
"Tricyclic compounds with OMA1/OPA1 modulatory properties" was invented by Marcel Victor Alavi Khorassani Moghadam (Berkeley, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Tricyclic compounds, and in particular novel dibenzoxazepin derivates are disclosed herein, which were quite surprisingly found as having OMA1 and/or OPA1 modulatory properties. Compounds of present invention may provide useful for the treatment of certain conditions and diseases, which are amenable to OMA1 and/or OPA1-modulatory therapies. Such conditions may include conditions and diseases prevalen...